332 related articles for article (PubMed ID: 38004401)
1. GluN2A and GluN2B N-Methyl-D-Aspartate Receptor (NMDARs) Subunits: Their Roles and Therapeutic Antagonists in Neurological Diseases.
Ladagu AD; Olopade FE; Adejare A; Olopade JO
Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004401
[TBL] [Abstract][Full Text] [Related]
2. Opportunities for Precision Treatment of
Han W; Yuan H; Allen JP; Kim S; Shaulsky GH; Perszyk RE; Traynelis SF; Myers SJ
J Pharmacol Exp Ther; 2022 Apr; 381(1):54-66. PubMed ID: 35110392
[TBL] [Abstract][Full Text] [Related]
3. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
4. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
Vizi ES; Kisfali M; Lőrincz T
Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
Ferreira IL; Bajouco LM; Mota SI; Auberson YP; Oliveira CR; Rego AC
Cell Calcium; 2012 Feb; 51(2):95-106. PubMed ID: 22177709
[TBL] [Abstract][Full Text] [Related]
7. Triheteromeric NMDA receptors: from structure to synaptic physiology.
Stroebel D; Casado M; Paoletti P
Curr Opin Physiol; 2018 Apr; 2():1-12. PubMed ID: 29682629
[TBL] [Abstract][Full Text] [Related]
8. The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.
Hamada S; Ogawa I; Yamasaki M; Kiyama Y; Kassai H; Watabe AM; Nakao K; Aiba A; Watanabe M; Manabe T
Eur J Neurosci; 2014 Oct; 40(8):3136-46. PubMed ID: 25131300
[TBL] [Abstract][Full Text] [Related]
9. Properties of Triheteromeric
Yi F; Zachariassen LG; Dorsett KN; Hansen KB
Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
[No Abstract] [Full Text] [Related]
10. Regulation of NMDA glutamate receptor functions by the GluN2 subunits.
Vieira M; Yong XLH; Roche KW; Anggono V
J Neurochem; 2020 Jul; 154(2):121-143. PubMed ID: 31978252
[TBL] [Abstract][Full Text] [Related]
11. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
Hansen KB; Ogden KK; Yuan H; Traynelis SF
Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230
[TBL] [Abstract][Full Text] [Related]
12. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
[TBL] [Abstract][Full Text] [Related]
13. The role of GluN2A and GluN2B NMDA receptor subunits in AgRP and POMC neurons on body weight and glucose homeostasis.
Üner A; Gonçalves GH; Li W; Porceban M; Caron N; Schönke M; Delpire E; Sakimura K; Bjørbæk C
Mol Metab; 2015 Oct; 4(10):678-91. PubMed ID: 26500840
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
15. Triclosan-Evoked Neurotoxicity Involves NMDAR Subunits with the Specific Role of GluN2A in Caspase-3-Dependent Apoptosis.
Szychowski KA; Wnuk A; Rzemieniec J; Kajta M; Leszczyńska T; Wójtowicz AK
Mol Neurobiol; 2019 Jan; 56(1):1-12. PubMed ID: 29675573
[TBL] [Abstract][Full Text] [Related]
16. Diversity in NMDA receptor composition: many regulators, many consequences.
Sanz-Clemente A; Nicoll RA; Roche KW
Neuroscientist; 2013 Feb; 19(1):62-75. PubMed ID: 22343826
[TBL] [Abstract][Full Text] [Related]
17. Early expression of GluN2A-containing NMDA receptors in a model of fragile X syndrome.
Banke TG; Traynelis SF; Barria A
J Neurophysiol; 2024 Apr; 131(4):768-777. PubMed ID: 38380828
[TBL] [Abstract][Full Text] [Related]
18. 7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
Kaniakova M; Kleteckova L; Lichnerova K; Holubova K; Skrenkova K; Korinek M; Krusek J; Smejkalova T; Korabecny J; Vales K; Soukup O; Horak M
Neuropharmacology; 2018 Sep; 140():217-232. PubMed ID: 30099049
[TBL] [Abstract][Full Text] [Related]
19. TCN 201 selectively blocks GluN2A-containing NMDARs in a GluN1 co-agonist dependent but non-competitive manner.
Edman S; McKay S; Macdonald LJ; Samadi M; Livesey MR; Hardingham GE; Wyllie DJ
Neuropharmacology; 2012 Sep; 63(3):441-9. PubMed ID: 22579927
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.
Cheriyan J; Balsara RD; Hansen KB; Castellino FJ
Neurosci Lett; 2016 Mar; 617():240-6. PubMed ID: 26917100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
